For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) (Sterne et al., 2019) was also used for RCTs to provide a domain-based qualitative evaluation, assessing risks related to selection, performance, detection, attrition, and reporting
Factors such as: Injury severity Chronicity Systemic inflammation Activity level Recovery goals Body size Overall health status may all influence how a protocol is structured
Always verify current clinical-trial and regulatory status through primary sources such as ClinicalTrials.gov, PubMed, and the FDA.
Aguilera, M., Vergara, P
Anti-Aging Effects: May reduce the visible and systemic signs of aging by supporting overall cellular health
In vitro assays show increased glycerol release from adipose tissue following exposure to AOD 9604, a widely used biochemical marker of active lipolysis [1]